The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
![Why Is Tadalafil So Hard to Find? [Explained for 2026]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Fvur4atr4%2Fproduction%2F79fd846f040010238ab4e7ea9c474e76a5f9a083-1024x1024.png%3Frect%3D0%2C256%2C1024%2C512%26w%3D600%26h%3D300%26auto%3Dformat&w=1200&q=75)
Why Is Tadalafil So Hard to Find? [Explained for 2026]
Having trouble finding Tadalafil at your pharmacy? Learn why this popular ED and BPH medication can be hard to find in 2026 and what you can do about it.
![Why Is Tamiflu So Hard to Find? [Explained for 2026]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Fvur4atr4%2Fproduction%2F5924b03a8a39a48c237402efcf48560723b7f54c-1024x1024.png%3Frect%3D0%2C256%2C1024%2C512%26w%3D600%26h%3D300%26auto%3Dformat&w=1200&q=75)
Why Is Tamiflu So Hard to Find? [Explained for 2026]
Tamiflu is hard to find in 2026 due to flu season demand surges, manufacturer allocation limits, and supply chain issues. Here's why and what to do.
Alinia Shortage: What Providers and Prescribers Need to Know in 2026
Nitazoxanide (Alinia) has no official FDA shortage in 2026, but providers face real access barriers. Learn strategies to help patients get this antiprotozoal.
Ezetimibe Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview of ezetimibe availability in 2026 for providers: shortage status, formulary navigation, therapeutic alternatives, and patient support strategies.
30,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.
Hydroquinone Access in 2026: What Providers and Prescribers Need to Know
Since the 2020 CARES Act moved hydroquinone to Rx-only, providers face new patient access challenges. Here's what prescribers need to know in 2026.
Isosorbide Shortage: What Providers and Prescribers Need to Know in 2026
The 2026 isosorbide shortage is straining cardiology practices nationwide. Here's what providers need to know about supply issues, prescribing alternatives, and supporting patients.
Januvia Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for prescribers on Januvia access challenges in 2026: supply status, cost barriers, savings programs, formulary considerations, and therapeutic alternatives.
Levetiracetam Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for neurologists, epileptologists, and primary care providers on managing levetiracetam supply disruptions and supporting affected patients in 2026.
Mecobalamin Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview of mecobalamin (methylcobalamin) availability in 2026 for providers. Understand the supply landscape, therapeutic alternatives, and how to help patients access their B12 therapy.
Nivestym Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for oncologists and prescribers on Nivestym (filgrastim-aafi) availability challenges in 2026, including biosimilar alternatives, formulary navigation, and patient support resources.
Otezla Shortage: What Providers and Prescribers Need to Know in 2026
Otezla isn't in FDA shortage, but patients face real access barriers. Here's what dermatologists, rheumatologists, and PCPs need to know to help their patients get it in 2026.
Pentoxifylline XR Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on Pentoxifylline XR availability in 2026: supply factors, evidence-based alternatives, patient communication strategies, and prescribing resources.